Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
During the current COVID-19 pandemic many spinal cord injury (SCI) rehabilitation services are limited to emergency management, leaving those living in the community without access to services. Unfortunately, this can lead to negative effects including increase in emotional distress, feelings of isolation, and decreased activity engagement. Due to their limited mobility and greater likelihood of respiratory illness it is imperative to provide alternative forms of activity engagement to reduce their risk for secondary complications. Physical activity has been demonstrate to have numerous benefits for individuals with SCI ranging from enhanced health through prevention of secondary complications to improved subjective well-being. The current study proposes to provide an online physical activity program through web-based videoconferencing to person with SCI to improve overall wellbeing and activity engagement. The program will consist of six weeks of twice-weekly, 45-minute sessions in which an experienced fitness instructor (i.e., wheelchair aerobics) with lived experience and a Kinesiology graduate student will lead online sessions. The sessions will be comprised of a 10-minute warm-up phase, a 25-minute aerobic phase and a 10-minute cool-down phase that will incorporate upper-extremity flexibility exercises and guided meditation. In all cases, remote (i.e., in-home) participant monitoring of physiological signals will be conducted by the instructor to ensure safety of participants. Once the program has been completed, participants will be asked to complete self-report questionnaires related to acceptability, feasibility, and limited effectiveness. Participants will also be asked to complete a brief semi-structured interview examining barriers and facilitators of the program. Participant feedback from the interviews will be used to further develop of the program to meet the needs of the population and develop sustainable approaches for access to care in the community setting through collaborations with community partners (SCI Ontario, National SCI Alliance, Ontario Neurotrauma Foundation). Ultimately, the proposed project aims to improve overall wellbeing and access to health care service for those with SCI during the COVID-19 quarantine.
Description: Treatment Satisfaction Questionnaire
Measure: Treatment Satisfaction Time: 6 weeksDescription: Spinal Cord Injury - Quality of Life Short Form
Measure: Ability to Participate in Social Roles and Activities Time: Baseline, 6 weeks, and at 3 month follow-upDescription: Spinal Cord Injury - Quality of Life Short Form
Measure: Fatigue Time: Baseline, 6 weeks, and at 3 month follow-upDescription: Spinal Cord Injury - Quality of Life Short Form
Measure: Satisfaction with Social Roles and Activities Time: Baseline, 6 weeks, and at 3 month follow-upDescription: Spinal Cord Injury - Quality of Life Short Form
Measure: Positive Affect and Well-Being Time: Baseline, 6 weeks, and at 3 month follow-upDescription: Spinal Cord Injury - Quality of Life Short Form
Measure: Pain Interference Time: Baseline, 6 weeks, and at 3 month follow-upDescription: Spinal Cord Injury - Quality of Life Short Form
Measure: Resilience Time: Baseline, 6 weeks, and at 3 month follow-upDescription: Spinal Cord Injury - Quality of Life Short Form
Measure: Self-Esteem Time: Baseline, 6 weeks, and at 3 month follow-upDescription: Fear of COVID-19 Scale
Measure: Fear of COVID-19 Scale Time: Baseline, 6 weeks, and at 3 month follow-upAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports